Endoscopic papillectomy for laterally spreading lesions of the papilla: a propensity score-matched analysis
- PMID: 40550486
- DOI: 10.1055/a-2641-0614
Endoscopic papillectomy for laterally spreading lesions of the papilla: a propensity score-matched analysis
Abstract
Endoscopic papillectomy is a standard treatment for ampullary lesions, which are typically small and confined to the papillary mound. Laterally spreading lesions (LSLs) of the papilla of Vater are a rare ampullary lesion subtype involving extensive duodenal mucosa. Data on endoscopic papillectomy outcomes for LSLs are limited. This study compared endoscopic papillectomy for ampullary LSLs and non-LSLs in matched cohorts.The ESAP study (Endoscopic papillectomy vs. Surgical Ampullectomy vs. Pancreaticoduodenectomy for ampullary neoplasm) encompassed 1422 endoscopic papillectomies. Propensity score matching used the nearest-neighbor method for age, sex, co-morbidity, and histologic subtype as cofactors. The main outcomes were complete resection (R0), technical success, complications, and recurrences.Propensity score-based matching identified 232 patients with ampullary lesions (116 non-LSL, 116 LSL) with comparable baseline characteristics. After first intervention, the R0 resection rate, the primary outcome measure, was significantly lower in the LSL group (54.3% [95%CI 45.3%-63.1%]) vs. 69.0% [95%CI 60.4%-76.6%]). Following repeated endoscopic interventions, technical success was similar in both groups (82.8%). After a 22-month median follow-up, the LSL group had significantly more recurrences (41.3% vs. 15.0%) and lower 1- and 3-year disease-free survival rates (61.1% and 44.0% vs. 86.1% and 81.6%, respectively). Complication rates did not differ significantly between the two groups (LSL 32.8% vs. non-LSL 26.7%).LSLs can be safely resected by endoscopic papillectomy, although repeated interventions are necessary to achieve complete resection. The higher risk of recurrence in LSLs necessitates a vigilant surveillance strategy.
Thieme. All rights reserved.
Conflict of interest statement
M.J. Bruno has received lecture fees and research support from Boston Scientific. M. Hollenbach has received honoraria from Fujifilm for lectures and expert panel participation. K.V. Trung, E. Abou-Ali, A. Gulla, K. Soares, F. Caillol, W.H. Paik, B. Napoleon, A. Halimi, V. Masaryk, E. Pérez-Cuadrado-Robles, L. Bolm, S. Seyfried, M.C. Petrone, B. Yilmaz, C. Vollmer, A. Berger, L. Maggino, P. Schemmer, D. Wichmann, E. Karam, A. Dugic, S. Regner, and S. Gaujoux declare that they have no conflict of interest.
LinkOut - more resources
Full Text Sources
